###### Strengths and limitations of this study

-   The strengths of the present study particularly result from the large cohort based on a complete, national patient sample and the long follow-up period.

-   We designed a cohort study to evaluate the risks of different types of stroke in migraineurs.

-   Migraine should be considered in assessments of the risk of ischaemic stroke, particularly in young women.

-   Confounders linking migraine to stroke, such as cigarette smoking, obesity and prescription information, were not available in the present cohort study based on claim data.

Introduction {#s1}
============

Migraine is a common neurovascular disorder characterised by recurrent disabling episodes of headache, most often unilateral headache. The headache is often accompanied by visual or sensory symptoms, namely, aura.[@R1] The annual prevalence of migraine is approximately 8%--15% worldwide,[@R2] and in South Korea, the estimated incidence is 6.1%.[@R4] Migraine appears to present at a relatively young age (\<45 years); it is more prevalent in women than men, with a prevalence \>25% in the 35--39-year-old female population worldwide.[@R1] The inclusion of migraine as an independent risk factor for cardiovascular and cerebrovascualr events has been debated for many years.[@R5]

Stroke is a cerebrovascular condition characterised by limited blood flow to the brain due to a blockage or rupture in the cerebrovascular system.[@R6] Stroke is responsible for approximately 700 000 deaths annually in the western world.[@R7] In South Korea, the estimated stroke incidence is approximately 795 000 in people aged ≥30 years.[@R8] More than 80% of stroke cases are ischaemic stroke, and the remaining cases are haemorrhagic stroke; ischaemic and haemorrhagic strokes differ with regard to risk factors, genetic predisposition and mortality rates.[@R9]

To date, several underlying physiological mechanisms have been suggested to explain the association between migraine and stroke. The risk factors for stroke in migraineurs have been widely evaluated, and common comorbidities, including hypertension, obesity, dyslipidaemia and smoking, were validated.[@R11] In addition, specific genetic aetiologies associated with vasculopathy can manifest in both patients suffering from migraine and stroke.[@R12] A recent investigation employing a mutant mouse model of migraine also indicated that shared genetic risk factors rendered the brain more vulnerable to ischaemic stroke.[@R13]

Moreover, migraine itself carries an increased risk of ischaemic stroke. Migraine is associated with an increased risk of perioperative ischaemic stroke in a large cohort of surgical patients, suggesting that migraine should be included in the perioperative risk assessment.[@R14] Recently, a population-based case-control study in Taiwan reported an association between migraine and ischaemic stroke (adjusted HR: 1.24), (CI: 1.12--1.38).[@R3] Similarly, an increased risk of ischaemic stroke has been consistently observed in migraineurs, especially in those diagnosed with migraine with aura.[@R3] Furthermore, accumulating evidence has supported the association between migraine and haemorrhagic stroke,[@R19] but the causative association currently remains unclear.

Given the differences in the natures of haemorrhagic stroke and ischaemic stroke in patients, including risk factors and genetic predispositions,[@R9] we hypothesised that the contributions of migraine to an increased risk of stroke differ according to the stroke type. Thus, stroke types should be analysed separately. Additionally, stroke is a leading cause of mortality; therefore, validation of the association between migraine and stroke may facilitate treatment and prognosis in these cases. Here, using a national South Korea population-based sample cohort, we examined the associations between migraine and different types of stroke.

Materials and methods {#s2}
=====================

Study population and data collection {#s2a}
------------------------------------

This national cohort study used data from the South Korea National Health Insurance Service-National Sample Cohort (NHIS-NSC). The South Korea NHIS selects samples directly from the entire population database to prevent non-sampling errors. Approximately 2% of the samples (one million) were selected from the entire South Korea population (50 million). The selected data were classified into 1476 levels (age \[18 categories\], sex \[two categories\] and income level \[41 categories\]) using randomised, stratified, systematic sampling methods via proportional allocation to represent the entire population. A previous study verified the appropriateness of the sample after data selection.[@R21] The National Health Insurance Sharing Service provides a detailed description of the methods used to perform these procedures.[@R22] This cohort database included (i) personal information, (ii) health insurance claim codes (procedures and prescriptions), (iii) diagnostic codes based on the International Classification of Disease-10 (ICD-10), (iv) death records from the South Korea National Statistical Office (using the South Korea Standard Classification of disease), (v) socioeconomic data (residence and income) and (vi) medical examination data for each participant from 2002 to 2013.

All South Korea citizens are recognised by a 13-digit resident registration number from birth to death. Therefore, exact population statistics have been determined using this database. All South Korea are required to enrol in the NHIS. All South Korea hospitals and clinics use the 13-digit resident registration number to register individual patients in the medical insurance system. Therefore, the risk of overlapping medical records is minimal, even if a patient moves from one place to another. All medical treatments in South Korea are tracked without exception using the Health Insurance Review & Assessment (HIRA) system. In South Korea, the law states that a notice of death must be provided to an administrative entity before a funeralcan be held. Medical doctors record the date and cause of death on a death certificate.

Patients and public involvement {#s2b}
-------------------------------

No patients or public were involved in the present study.

Participant selection {#s2c}
---------------------

Of the 1 125 691 patients with 114 369 638 medical claim codes, participants diagnosed with migraine (ICD-10: G43) were included. Among these participants, those who were treated ≥two times (n=45 587) were selected. The participants were followed for 12 years.

The history of admission for haemorrhagic stroke (I60: subarachnoid haemorrhage, I61: intracerebral haemorrhage and I62: other non-traumatic intracranial haemorrhage) and ischaemic stroke (I63: cerebral infarction) was identified using ICD-10 codes. We selected the participants who were treated ≥one time. These methods were used in other studies evaluating the incidence of stoke in South Korea.[@R8]

The participants with migraine were matched 1:4 with participants (control group) who had never been diagnosed with a migraine from 2002 through 2013 in this cohort. The control group was selected from the total population (n=1 080 104). The matches were processed for age, group, sex, income group, region of residence and medical histories (age, sex, income, region of residence, hypertension, diabetes and dyslipidaemia histories). We sorted the participants in the control group using a random number order and then selected them from top to bottom to prevent selection bias when selecting the matched control participants. We assumed that the matched control participants were enrolled at the same time as each matched participant with migraine (index date). Therefore, control group members who died before the index date were excluded. In both the migraine and control groups, participants with histories of haemorrhagic or ischaemic stroke before the index date were excluded. In the migraine group, 438 participants were excluded. The participants with migraine for whom we were unable to identify sufficient numbers of matching participants were excluded (n=185). We excluded participants aged less than 20 years (n=3379). Finally, 1:4 matching resulted in the inclusion of 41 585 participants with migraine (migraine with aura=3458, migraine without aura=38 127) and 166 340 control participants ([figure 1](#F1){ref-type="fig"}).

![A schematic illustrating the participant selection process used in the present study. Of a total of 1 125 691 participants, 41 585 participants with migraine were matched with 166 340 control participants for age, group, sex, income level, region of residence and medical histories.](bmjopen-2018-027701f01){#F1}

Variables {#s2d}
---------

The age groups were classified using 5-year intervals: aged 20--24, 25--29, 30--34..., and 85+ years. Fourteen age groups were designated. The income groups were initially divided into 41 classes (one health aid class, 20 self-employment health insurance classes and 20 employment health insurance classes). These groups were recategorised into 11 classes (class 1 \[lowest income\]--class 11 \[highest income\]). The region of residence was divided into 16 areas according to administrative district. These regions were regrouped into urban (Seoul, Busan, Daegu, Incheon, Gwangju, Daejeon and Ulsan) and rural (Gyeonggi, Gangwon, Chungcheongbuk, Chungcheongnam, Jeollabuk, Jeollanam, Gyeongsangbuk, Gyeongsangnam and Jeju) areas. The medical histories of the participants were evaluated using ICD-10 codes. For an accurate diagnosis, hypertension (I10 and I15), diabetes (E10-E14) and dyslipidaemia (E78) were recorded if the participants were treated ≥two times. Using the Charlson comorbidity index, we selected some of confounders that might affect the association between migraine and stroke as confounders based on literature review. We performed the analysis with added variables, including congestive heart failure,[@R24] myocardial infarction,[@R25] peripheral vascular disease,[@R26] pulmonary disease,[@R27] liver disease[@R28] and depression histories.[@R29] Thus, the new model was adjusted for age, sex, income, region of residence, hypertension, diabetes, dyslipidaemia, congestive heart failure, myocardial infarction, peripheral vascular disease, pulmonary disease, liver disease and depression histories.

Statistical analyses {#s2e}
--------------------

χ^2^ tests were used to compare the general characteristics between the migraine and control groups. For the analysis of the HRs of migraine for haemorrhagic stroke and ischaemic stroke, Cox proportional hazard models were used, and 95% CIs were calculated. In these analyses, crude (simple) and adjusted (age, sex, income, region of residence, hypertension, diabetes, dyslipidaemia, congestive heart failure, myocardial infarction, peripheral vascular disease, pulmonary disease, liver disease and depression histories) models were used. For the subgroup analysis, we stratified the participants by age and sex (aged 20--39 years, 40--59 years, 60+ years; men and women). Two-tailed analyses were conducted, and p values less than 0.05 were considered significant. The results were statistically analysed using SPSS V.21.0 software (IBM, Armonk, NY, USA).

Results {#s3}
=======

The mean follow-up period was 80.9 (SD=41.6) months for patients with migraine and 80.9 (SD=41.6) months for controls. The rates of haemorrhagic stroke were similar in the migraine group (0.7% \[295/41 585\]) and the control group (0.7% \[1113/166 340\], P=0.370, [table 1](#T1){ref-type="table"}). Higher rates of ischaemic stroke were observed in the migraine group (2.3% \[964/41 585\]) than in the control group (2.0% \[3294/166 340\], P\<0.001). The general characteristics (age, sex, income, region of residence, hypertension, diabetes and dyslipidaemia histories) of participants were the same due to the matching protocol (P=1.000).

###### 

General characteristics of the participants

  Characteristics               Total participants                    
  ----------------------------- -------------------- ---------------- -----------
  Age (years)                                                         1.000
   20--24                       1994 (4.8)           7976 (4.8)       
   25--29                       2649 (6.4)           10 596 (6.4)     
   30--34                       3640 (8.8)           14 560 (8.8)     
   35--39                       4309 (10.4)          17 236 (10.4)    
   40--44                       4859 (11.7)          19 436 (11.7)    
   45--49                       5187 (12.5)          20 748 (12.5)    
   50--54                       4512 (10.9)          18 048 (10.9)    
   55--59                       3508 (8.4)           14 032 (8.4)     
   60--64                       3209 (7.7)           12 836 (7.7)     
   65--69                       3049 (7.3)           12 196 (7.3)     
   70--74                       2328 (5.6)           9312 (5.6)       
   75--79                       1423 (3.4)           5692 (3.4)       
   80--84                       651 (1.6)            2604 (1.6)       
   85+                          267 (0.6)            1068 (0.6)       
  Sex                                                                 1.000
   Male                         10 476 (25.2)        41 904 (25.2)    
   Female                       31 109 (74.8)        124 436 (74.8)   
  Income                                                              1.000
   1 (lowest)                   837 (2.0)            3348 (2.0)       
   2                            3170 (7.6)           12 680 (7.6)     
   3                            3004 (7.2)           12 016 (7.2)     
   4                            3131 (7.5)           12 524 (7.5)     
   5                            3345 (8.0)           13 380 (8.0)     
   6                            3615 (8.7)           14 460 (8.7)     
   7                            3908 (9.4)           15 632 (9.4)     
   8                            4411 (10.6)          17 644 (10.6)    
   9                            4908 (11.8)          19 632 (11.8)    
   10                           5456 (13.1)          21 824 (13.1)    
   11 (highest)                 5800 (13.9)          23 200 (13.9)    
  Region of residence           1.000                                 
   Urban                        17 959 (43.2)        71 836 (43.2)    
   Rural                        23 626 (56.8)        94 504 (56.8)    
  Hypertension                  16 209 (39.0)        64 836 (39.0)    1.000
  Diabetes                      7261 (17.5)          29 044 (17.5)    1.000
  Dyslipidaemia                 12 837 (30.9)        51 348 (30.9)    1.000
  Congestive heart failure      2030 (4.9)           6761 (4.1)       \<0.001\*
  Myocardial infarction         913 (2.2)            3330 (2.0)       0.013\*
  Peripheral vascular disease   7942 (19.1)          20 217 (12.2)    \<0.001\*
  Pulmonary disease             29 540 (71.0)        94 811 (57.0)    \<0.001\*
  Liver disease                 5087 (12.2)          15 317 (9.2)     \<0.001\*
  Depression                    7808 (18.8)          15 269 (9.2)     \<0.001\*
  Haemorrhagic stroke           295 (0.7)            1113 (0.7)       0.370
  Ischaemic stroke              964 (2.3)            3294 (2.0)       \<0.001\*

The crude and adjusted HRs for haemorrhagic stroke were 1.06 (95% CI=0.93 to 1.21, P=0.369) and 1.10 (95% CI=0.96 to 1.25, P=0.172), respectively, in the migraine group ([table 2](#T2){ref-type="table"}). The crude and adjusted HRs for ischaemic stroke were 1.17 (95% CI=1.09 to 1.26) and 1.18 (95% CI=1.08 to 1.25), respectively, in the migraine group (each P\<0.001).

\*χ^2^ test. Differences were considered significant at P\<0.05.

###### 

Crude and adjusted HRs (95% CI) of migraine for haemorrhagic stroke and ischaemic stroke

  Characteristics   Haemorrhagic stroke   Ischaemic stroke                                                                                    
  ----------------- --------------------- ------------------ ------------------- ------- --------------------- ---------- ------------------- ----------
  Migraine                                0.369                                  0.172                         \<0.001†                       \<0.001†
   Yes              1.06 (0.93 to 1.21)                      1.10 (0.96--1.25)           1.17 (1.09 to 1.26)              1.17 (1.08--1.25)   
   No               1.00                                     1.00                        1.00                             1.00                

\*Model adjusted for age, sex, income, region of residence, hypertension, diabetes, dyslipidaemia, congestive heart failure, myocardial infarction, peripheral vascular disease, pulmonary disease, liver disease and depression histories.

†Cox proportional hazard regression model; differences were considered significant at P\<0.05.

In the subgroup analyses, none of the crude and adjusted HRs for haemorrhagic stroke reached statistical significance ([table 3](#T3){ref-type="table"}). Among the patients with ischaemic stroke, young women, middle-aged women and old women showed statistically significant differences (each P\<0.05). The significant adjusted HRs were 2.31 (95% CI=1.39 to 3.82) in young women (aged 20--39 years); 1.32 (95% CI=1.08 to 1.61) in middle-aged women (aged 40--59 years); and 1.18 (95% CI=1.06 to 1.30) in ≥60 year-old women. Moreover, descriptive statistical analyses of the migraine prevalence and ischaemic stroke occurrence within subgroups revealed statistically significant differences in young men, young women, middle-aged women, old men and old women. On the other hand, the risk of haemorrhagic stroke in patients with migraine was not significantly different from the control group (online [supplementary table 1](#SP1){ref-type="supplementary-material"}).
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###### 

Subgroup analysis of crude and adjusted HRs (95% CI) of migraine for haemorrhagic stroke and ischaemic stroke

  Characteristics                                      Haemorrhagic stroke   Ischaemic stroke                                                                                    
  ---------------------------------------------------- --------------------- ------------------ ------------------- ------- --------------------- ---------- ------------------- --------
  Young men (aged 20--39  years, n = 15 550)                                                                                                                                     
  Migraine                                                                   0.158                                  0.330                         0.017†                         0.107
   Yes                                                 1.56 (0.84 to 2.89)                      1.37 (0.73--2.59)           2.15 (1.15 to 4.02)              1.72 (0.89--3.32)   
   No                                                  1.00                                     1.00                        1.00                             1.00                
  Young women (aged 20--39  years, n = 47 410)                                                                                                                                   
  Migraine                                                                   0.726                                  0.879                         \<0.001†                       0.001†
   Yes                                                 1.10 (0.64 to 1.92)                      1.05 (0.59--1.84)           2.54 (1.55 to 4.15)              2.31 (1.39--3.82)   
   No                                                  1.00                                     1.00                        1.00                             1.00                
  Middle-aged men (aged 40--59  years, n = 22 090)                                                                                                                               
  Migraine                                                                   0.721                                  0.668                         0.565                          0.418
   Yes                                                 1.07 (0.73 to 1.56)                      1.09 (0.74--1.61)           0.93 (0.71 to 1.21)              0.89 (0.68--1.17)   
   No                                                  1.00                                     1.00                        1.00                             1.00                
  Middle-aged women (aged 40--59  years, n = 68.240)                                                                                                                             
  Migraine                                                                   0.582                                  0.388                         0.002†                         0.006†
   Yes                                                 1.07 (0.84 to 1.38)                      1.12 (0.87--1.44)           1.35 (1.12 to 1.64)              1.32 (1.08--1.61)   
   No                                                  1.00                                     1.00                        1.00                             1.00                
  Old men (aged ≥ 60  years, n = 14 740)                                                                                                                                         
  Migraine                                                                   0.115                                  0.068                         0.275                          0.353
   Yes                                                 1.29 (0.94 to 1.78)                      1.36 (0.98--1.88)           1.09 (0.93 to 1.27)              1.08 (0.92--1.26)   
   No                                                  1.00                                     1.00                        1.00                             1.00                
  Old women (aged ≥ 60  years, n = 39 895)                                                                                                                                       
  Migraine                                                                   0.462                                  0.757                         0.002†                         0.002†
   Yes                                                 0.92 (0.75 to 1.14)                      0.97 (0.78--1.20)           1.17 (1.06 to 1.29)              1.18 (1.06--1.30)   
   No                                                  1.00                                     1.00                        1.00                             1.00                

\*Model adjusted for age, sex, income, region of residence, hypertension, diabetes, dyslipidaemia, congestive heart failure, myocardial infarction, peripheral vascular disease, pulmonary disease, liver disease, and depression histories.

†Cox proportional hazard regression model; differences were considered significant at P\<0.05.

Compared with the control group, participants who reported migraine with aura and migraine without aura had increased adjusted HRs of 1.44 (95% CI=1.09 to 1.89) and 1.15 (95% CI=1.06 to 1.24) for ischaemic stroke, respectively, but no increased risk of haemorrhagic stroke ([table 4](#T4){ref-type="table"}).

###### 

Subgroup analysis of crude and adjusted HRs (95% CI) of migraine for haemorrhagic stroke and ischaemic stroke

  Characteristics                        Haemorrhagic stroke   Ischaemic stroke                                                                                    
  -------------------------------------- --------------------- ------------------ ------------------- ------- --------------------- ---------- ------------------- ----------
  Migraine with aura (n = 17 290)                                                                                                                                  
  Migraine                                                     0.531                                  0.506                         0.006†                         0.009†
   Yes                                   1.17 (0.72 to 1.90)                      1.19 (0.72--1.96)           1.45 (1.11 to 1.88)              1.44 (1.09--1.89)   
   No                                    1.00                                     1.00                        1.00                             1.00                
  Migraine without aura (n = 1 90 635)                                                                                                                             
  Migraine                                                     0.446                                  0.213                         \<0.001†                       \<0.001†
   Yes                                   1.05 (0.92 to 1.20)                      1.09 (0.95--1.25)           1.16 (1.07 to 1.24)              1.15 (1.06--1.24)   
   No                                    1.00                                     1.00                        1.00                             1.00                

\*Model adjusted for age, sex, income, region of residence, hypertension, diabetes, dyslipidaemia, congestive heart failure, myocardial infarction, peripheral vascular disease, pulmonary disease, liver disease and depression histories.

†Cox proportional hazard regression model; differences were considered significant at P\<0.05.

Discussion {#s4}
==========

Migraine appeared to increase the risk of ischaemic stroke, but not haemorrhagic stroke. The risk of ischaemic stroke was 1.18-fold greater in the patients with migraine than in the matched control subjects, even after adjustment for confounding factors. In the subgroup analyses stratified by age and sex, significant correlations with ischaemic stroke were primarily observed in young women, middle-aged women and old women. In contrast, the risk of haemorrhagic stroke was similar in patients with migraine and the matched control patients.

Migraine, particularly migraine with aura, is an established risk factor for ischaemic stroke. In this study, compared with the control group, participants who reported migraine with aura had an increased adjusted HR of 1.44 (95% CI=1.09 to 1.89) for ischaemic stroke. Migraine with aura particularly increases the risk of ischaemic stroke, based on the results of large population-based cohort studies and meta-analyses.[@R3]Cortical spreading depression (CSD) is a self-propagating wave of depolarization across the cerebral cortex at a slow velocity of 3--5 mm/min.[@R31] CSD has been implicated in migraine with aura, which plays a critical role in the pathophysiology of ischaemic stroke. In an experimental study, CSD altered the tone of resistance vessels, causing hypoperfusion in tissues at risk for progressive damage, namely, cortical spreading ischaemia.[@R32]In addition, the inflammatory cascade of the neurovascular system, which is characterised by endothelial dysfunction and coagulation abnormalities, may contribute to the development of ischaemic stroke. In the aura phase, the endothelium activates coagulation and thrombosis, which are mediated by inflammatory cytokines and endothelial biomarkers.[@R33] Moreover, specific genetic aetiologies, such as factor V Leiden G 619 1A, prothrombin G20210A and familial hemiplegic migraine type 1, have been reported in patients diagnosed with migraine with aura. These shared genetic factors may precipitate the susceptibility to CSD, which may explain the association between migraine and stroke.[@R35]

A growing body of evidence regarding the increased risk of ischaemic stroke in patients with migraine without aura. Consistent with the findings from patients reporting migraine with aura, participants who reported migraine without aura had an increased adjusted HR of 1.15 (95% CI=1.06 to 1.24) for ischaemic stroke compared with the control group. Notably, a significant association was observed in cases of ischaemic stroke resulting from cervical artery dissection.[@R36] In addition, genetic overlaps among subjects with migraine without aura, large artery stroke, and cardioembolic stroke have been identified.[@R37] However, strong evidence has been not reported. A recent large population-based study reported an statistically insignificant risk of ischaemic stroke in patients with migraine without aura but an increased risk in patients with migraine with aura.[@R3] The study suggested that the difference may be due to changes in the lipid profile, the susceptibility to thrombosis, and genetic predisposition.[@R3] A meta-analysis did not identify a significant association between migraine without aura and ischaemic stroke.[@R18] In the present study, we did not differentiate between migraine subtypes, such as migraine with and without aura, when analysing the risk of stroke. Therefore, the risk of ischaemic stroke in participants with migraine was relatively low but statistically significant compared with other studies investigating specific conditions.

Notably, in the present study, migraine was not associated with an increased risk of haemorrhagic stroke. In contrast to the findings from the present study, a recent meta-analysis based on four case-control and four cohort studies concluded that migraine may increase the risk of haemorrhagic stroke.[@R20] However, a recent large population-based case-control study did not show an association with different types of haemorrhagic stroke, including intracerebral haemorrhage and subarachnoid haemorrhage.[@R38] Migraine was an independent risk factor for aneurismal rupture (OR (OR)=2.4; 95% CI 1.1 to 5.1) in a case-control study,[@R39] and even if headache is a premonitory symptom of aneurismal rupture, recall biases might have affected the results of the study. Overall, the relatively small number of haemorrhagic stroke cases might have resulted in decreased statistical power.

In our subgroup analysis, a strong correlation between migraine and ischaemic stroke was observed in young patients, specifically young women (aged 20--39 years). Based on a consensus statement from the European Headache Federation,[@R40] the use of a combined hormonal contraceptive may further increase the risk of ischaemic stroke in patients with migraine, specifically migraine with aura, supporting our results. Because the predisposing factors for stroke increase the incidence of ischaemic stroke with age,[@R41] migraine itself rather than other risk factors might be implicated in the increased risk of ischaemic stroke. In contrast, a recent large, population-based cohort study in Taiwan with a relatively short follow-up duration of 3.6 years did not show a significant association in the subgroups of women and patients aged \<45 years.[@R3] This discrepancy might be due to differences in the study design, follow-up duration and ethnic composition of the study population. Recently, a similar trend for this association was also reported,[@R3] but it requires further confirmation due to the lack of evidence at present.

The present study has several strengths. The results of this study are consistent with the findings of our previous studies using the HIRA-NSC.[@R42] We examined a very large, representative and nationwide population. Because the NHIS data cover all citizens of South Korea without exception, no participants were lost during follow-up. The control group was randomly selected and matched based on age, sex, income, region of residence and medical history to decrease any confounding effects. An adjusted hazard model was used to further minimise the impacts of confounders. Because migraine attacks might be frequently repeated, we opted to include patients with migraine who underwent treatment at least twice based on the ICD-10 code to increase the validity of the study (G43). In a previous study, the prevalence of migraine in South Korea was reported to be approximately 6.1%.[@R4] This value appeared to be slightly higher than the value reported in the present study, which was 3.7% (41 585/1 125 691), based on strict inclusion criteria for migraine. In addition, the patients with migraine were followed for 12 years in the present study. Long study periods enable the recruitment of a large study population and allow researchers to observe and analyse the delayed effects of migraine on stroke.

However, the present study has certain limitations that should be addressed in future studies. First, we were unable to extract information on stroke subtypes and location from the data used in the present study. The impact of migraine on each type of pathophysiology might vary when considering different functional outcomes, survival and recurrence according to stroke subtype.[@R38] However, in the present study, the distribution of stroke subtypes was not available. The classification of stroke type can lead to a significantly decreased incidence of each disease. As an insufficient number of cases cause inappropriate comparisons due to lower statistical power, the inclusion of the distribution of stroke subtypes would hamper our ability to draw a clear conclusion from the available data. In particular, the absolute incidence of haemorrhagic stroke is very low in general practice; therefore, most of studies did not provide information about subtypes, such as the presence of an aneurysm, although the association is positive in public health studies.[@R38] Second, a firm correlation between the frequency of migraine attacks and the risk of stroke has been reported,[@R46] but we were unable to confirm this correlation using the claim data analysed in the present study. Similarly, the duration and severity of migraine were inconsistent among the study population. Patients with migraine who had mild symptoms may not have received a consultation at the clinic; therefore, the impact of migraine on stroke may be underestimated in this study. Third, although this study attempted to include a large, representative patient population and subsequently matched and adjusted for possible confounders, the risk factors for stroke in patients with migraine, such as cigarette smoking, obesity and migraine-specific drugs, were not available in the insurance database.[@R11] Finally, in the present study, the incidence of migraine was 3.7% (41 585 of 1 125 691 participants) after employing a strict matching protocol. Before matching, the incidence of migraine in South Korea was 4.1% (45 587 of 1 125 691 participants). This value is consistent with previous cohort study in South Korea, indicating that the overall prevalence rate of migraine was 6.1%,[@R4] despite the use of different study designs. Given the global prevalence of migraine of approximately 8%--15%,[@R2] the incidence of migraine in South Korea is relatively low because of limited claim data. Only patients with migraine who visited the hospital are recorded. In other words, data are not available for patients with weak migraine symptoms or patients who do not visit a hospital, leading to a lower incidence. Based on a population-based epidemiological study of migraine in South Korea, only 24.4% of patients ever consulted a doctor for headache and only 3.3% of patients were prescribed a drug by a doctor.[@R47]

Conclusions {#s5}
===========

Based on a large population-based cohort study in South Korea, migraine increased the risk of ischaemic stroke, but not haemorrhagic stroke. The subgroup of patients at the highest risk of developing ischaemic stroke was young women.
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